These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia. Youssef DL, Narayanan P, Gill N. Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457 [Abstract] [Full Text] [Related]
11. A review of clozapine safety. Fitzsimons J, Berk M, Lambert T, Bourin M, Dodd S. Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451 [Abstract] [Full Text] [Related]
12. Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine. Wehmeier PM, Schüler-Springorum M, Heiser P, Remschmidt H. J Child Adolesc Psychopharmacol; 2004 Jul; 14(2):267-71. PubMed ID: 15319023 [Abstract] [Full Text] [Related]
18. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review. Knoph KN, Morgan RJ, Palmer BA, Schak KM, Owen AC, Leloux MR, Patel M, Leung JG. Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760 [Abstract] [Full Text] [Related]
19. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease. Masopust J, Urban A, Valis M, Malý R, Tůma I, Hosák L. Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384 [Abstract] [Full Text] [Related]
20. Update on the adverse effects of clozapine: focus on myocarditis. De Berardis D, Serroni N, Campanella D, Olivieri L, Ferri F, Carano A, Cavuto M, Martinotti G, Cicconetti A, Piersanti M, Saverio Moschetta F, Di Giannantonio M. Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]